TNF and rheumatoid arthritis: Baseline levels of glutamine in the urine or serum of RA patients also contributed to two independent metabolite profiles that could distinguish clinical responders versus non-responders to anti-TNFα therapy, with elevated glutamine levels associating with a favourable response (109, 110).